Adipose-Derived Molecules–Untouched Horizons in Alzheimer’s Disease Biology

  title={Adipose-Derived Molecules–Untouched Horizons in Alzheimer’s Disease Biology},
  author={Pichiah Balasubramanian Tirupathi Pichiah and Devaraj Sankarganesh and Sankarganesh Arunachalam and Shanmugam Achiraman},
  journal={Frontiers in Aging Neuroscience},
The global incidence of Alzheimer’s disease (AD) is on the rise with the increase in obesity and metabolic disease epidemic. Obesity is co-morbid with the increase in mass of adipose tissue, which secretes numerous molecules that are biologically important. Obesity and its associated conditions are perhaps involved in the causative pathway of AD. Immunologically important cytokines such as IL-1β, IL-10, and IL-18, which are released by adipose tissue, are also found to be associated with AD… 
The Other Side of Alzheimer’s Disease: Influence of Metabolic Disorder Features for Novel Diagnostic Biomarkers
These findings revise the canonical understating of AD pathogenesis and suggest that AD has metabolic disorder features, and highlight the contribution of this novel understanding on the identification of new biomarkers for improving an early AD diagnosis.
Adiponectin, Leptin, and Resistin and the Risk of Dementia
The hypothesis that adipokines have a role in the pathophysiology of dementia is supported after a case–cohort study embedded in the prospective, population-based Rotterdam Study.
Association between Visceral Adipose Tissue Metabolism and Alzheimer’s Disease Pathology
VAT metabolism was associated with AD pathology in older subjects and the findings suggest that VAT dysfunction could contribute to AD development.
HyMM: Hybrid method for disease-gene prediction by integrating multiscale module structures
This work proposes a hybrid method, HyMM, to predict disease-related genes more effectively by integrating the information from multiscale module structures, and shows that the functional consistency of the modules gradually improves as the resolution increases.


Obesity as a risk factor for Alzheimer’s disease: the role of adipocytokines
This paper pretends to review the existing evidence on the contribution of adipocytokines dysfunction to the increased risk of dementia associated with mid-life obesity, unraveling its insulin-independent effects on cognition.
Pro-inflammatory interleukin-18 increases Alzheimer’s disease-associated amyloid-β production in human neuron-like cells
The IL-18 induction of BACE-1, APP processing, and Aβ is likely to be linked to stress-associated adaptations in neurons during the course of normal functioning and development, including via increased Aβ.
Adipocytokines and CD34+ Progenitor Cells in Alzheimer's Disease
Low plasma levels of leptin and circulating CD34+ progenitor cells could represent an important molecular link between atherosclerotic diseases and AD and the results of this study provide first evidence that increased leptin plasma levels are associated with a reduced number of CD34-progenitor cells in AD patients.
A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
It has been observed in epidemiological studies that treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) decreases the risk for developing AD, and Supplementation of these natural compounds may provide a new therapeutic line of approach to this brain disorder.
Obesity, adiponectin and vascular inflammatory disease
Adiponectin is an endogenous biologically relevant modulator of vascular remodeling linking obesity and vascular disease, and acts as an anti-inflammatory and anti-atherogenic plasma protein.
Adipokines in inflammation and metabolic disease
The role of adipokines in inflammatory responses is focused on and their potential as regulators of metabolic function is discussed.
Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease
It is concluded that lower levels of adiponectin were associated with cognitive dysfunction, though it did not predict additional cognitive decline and conversion to dementia in this cohort of elderly subjects.
Hyperglycemia Activates Caspase-1 and TXNIP-Mediated IL-1β Transcription in Human Adipose Tissue
Whether hyperglycemia drives IL-1β production and caspase-1 activation in murine and human adipose tissue, thus inducing insulin resistance, is investigated and TXNIP suppression in human adipocytes counteracted the effects of high glucose on bioactiveIL-1 production.
Monocyte Chemoattractant Protein‐1 Plays a Dominant Role in the Chronic Inflammation Observed in Alzheimer's Disease
The data support previous work on significant increases in IL‐6 and IL‐8 in AD but indicate that MCP‐1 may play a more dominant role in chronic inflammation in AD.
Inflammasomes as therapeutic targets for Alzheimer's disease
NLRP3 and NLRP1 inflammasomes have been found to be integral in pathogenic neuroinflammation in animal models of Alzheimer's disease and are very promising novel pharmacological targets which merit further research in the continued endeavor for efficacious therapeutics for Alzheimer’s disease.